サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1696292

医療ガスの世界市場：2025年～2033年

Global Medical Gas Market - 2025-2033

出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療ガスの世界市場：2025年～2033年
出版日: 2025年03月25日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の医療ガスの市場規模は、2024年に189億8,000万米ドルに達し、2033年には683億1,000万米ドルに達すると予測され、予測期間の2025年～2033年のCAGRは13.6%となる見込みです。

医療ガスは、治療、診断、製薬など様々な医療用途で使用される特殊なカテゴリーです。酸素、亜酸化窒素、二酸化炭素、ヘリウム、窒素、医療用空気などが含まれます。酸素はCOPDや低酸素血症などの症状における呼吸補助に使用され、亜酸化窒素は外科手術における麻酔薬として使用されます。二酸化炭素は低侵襲手術の気腹に重要であり、ヘリウムは呼吸器治療に使用されます。

窒素は冷凍保存や医療研究に不可欠であり、医療用空気は人工呼吸器や患者ケア環境に使用されます。医療ガスの需要は、呼吸器疾患、外科技術、在宅ヘルスケア分野の拡大により増加しています。ガス供給システムやヘルスケアインフラの革新により、市場は世界の成長が見込まれています。

純医療ガス市場の成長は、COPD、喘息、睡眠時無呼吸症候群のような呼吸器疾患の有病率の上昇が牽引しています。また、高齢者人口の増加、汚染レベル、工業排出物、喫煙率の上昇により、高純度医療ガスの需要も増加しています。ヘルスケア施設の拡大、在宅ケアサービス、ガス供給システムの進歩は、呼吸器治療に高純度医療ガスを広く採用する上で極めて重要です。

例えば、COPD、喘息、肺がん、職業性肺疾患などを含む慢性呼吸器疾患（CRDs）は、5,500億人の成人に影響を与え、全死亡の7％を占める重大な世界的健康問題です。肺がんはさらに年間14億人の死亡の原因となっています。5歳未満の子供は特に肺疾患の影響を受けやすく、喘息は最も一般的な慢性疾患です。1990年から2017年の間に有病率が40％増加したにもかかわらず、CRDは他の非感染性疾患に比べてあまり注目されてきませんでした。

したがって、慢性呼吸器疾患（CRDs）の有病率の上昇は、CRD管理へのヘルスケア投資と意識の高まりとともに、酸素療法や吸入治療のような医療用ガスの需要を促進しています。

FDA、USP、ISOのような組織によって設定された純粋な医療用ガスの製造、貯蔵、輸送に関する厳しい規制は、市場成長にとって大きな課題となっており、新規参入を制限し、市場拡大に影響を与える可能性があります。

当レポートでは、世界の医療ガス市場について調査し、市場の概要とともに、製品タイプ別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 エグゼクティブの洞察と重要なポイント

第3章 市場のハイライトと戦略的ポイント

  • 主な動向と将来の予測

第4章 製品タイプ別概要

  • 用途別
  • エンドユーザー別
  • 地域別

第5章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第6章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第7章 製品タイプ別

  • 純粋ガス
  • ガス混合物
  • その他

第8章 用途別

  • 呼吸療法
  • 心臓血管治療
  • 麻酔
  • 凍結療法
  • その他

第9章 エンドユーザー別

  • 病院・クリニック
  • 外来手術センター（ASC）
  • 在宅ヘ療
  • 製薬会社・バイオテクノロジー企業

第10章 地域市場分析と成長機会

第11章 イントロダクション

  • 北米
    • 地域特有の主な動向
      • 米国
      • カナダ
  • 欧州
    • 地域特有の主要な動向
      • ドイツ
      • 英国
      • フランス
      • スペイン
      • イタリア
      • その他
  • ラテンアメリカ
    • 地域特有の主な動向
      • メキシコ
      • ブラジル
      • アルゼンチン
      • その他
  • アジア太平洋
    • 地域特有の主な動向
      • 中国
      • インド
      • 日本
      • 韓国
      • その他
  • 中東・アフリカ
    • 地域特有の主要な動向

第12章 競合情勢と市場ポジショニング

第13章 競合状況の概要と主要参入企業

  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第14章 企業プロファイル

  • Air Liquide

第15章 財務概要

  • 会社の収益
    • 地域別収益分配
    • 主な発展
    • SWOT分析
  • Linde plc
  • Air Products and Chemicals, Inc.
  • Messer Group GmbH
  • SOL Group
  • Matheson Tri-Gas, Inc.
  • Atlas Copco
  • GCE Group
  • Nova Gas Technologies
  • Gruppo SIAD

第16章 仮定と調査手法

第17章 付録

目次
Product Code: MD9412

The global medical gas market reached US$ 18.98 billion in 2024 and is expected to reach US$ 68.31 billion by 2033, growing at a CAGR of 13.6% during the forecast period 2025-2033.

Medical gas is a specialized category used in various medical applications, including therapeutic, diagnostic, and pharmaceutical. It includes oxygen, nitrous oxide, carbon dioxide, helium, nitrogen, and medical air. Oxygen is used for respiratory support in conditions like COPD and hypoxemia, while nitrous oxide is used as an anaesthetic in surgical procedures. Carbon dioxide is crucial for insufflation during minimally invasive surgeries, and helium is used in respiratory treatments.

Nitrogen is essential in cryopreservation and medical research, while medical air is used in ventilators and patient care environments. The demand for medical gases has increased due to respiratory diseases, surgical techniques, and the expanding home healthcare sector. The market is expected to grow globally due to innovations in gas delivery systems and healthcare infrastructure.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Respiratory Disorders

The growth of the pure medical gases market is driven by the increasing prevalence of respiratory diseases like COPD, asthma, and sleep apnea. The demand for high-purity medical gases is also increasing due to the growing elderly population, pollution levels, industrial emissions, and higher smoking rates. The expansion of healthcare facilities, home care services, and advancements in gas delivery systems are crucial for the widespread adoption of pure medical gases for respiratory treatments.

For instance, Chronic respiratory diseases (CRDs), including COPD, asthma, lung cancer, and occupational lung diseases, are significant global health issues affecting 550 billion adults and accounting for 7% of all deaths. Lung cancer contributes to another 1.4 billion deaths annually. Children under five are particularly affected by lung diseases, with asthma being the most common chronic condition. Despite a 40% increase in prevalence between 1990 and 2017, CRDs have received less attention than other NCDs.

Hence, the increasing prevalence of chronic respiratory diseases (CRDs) drives demand for medical gases like oxygen therapy and inhaled treatments, with increased healthcare investments and awareness in CRD management.

Stringent Regulatory Requirements

The strict regulations on the production, storage, and transportation of pure medical gases, set by organizations like the FDA, USP, and ISO, are posing a significant challenge to market growth, potentially limiting new player entry and affecting market expansion.

Segment Analysis

The global medical gas market is segmented based on product type, application, end-user, and region.

Product Type:

The pure gases from product type segment is expected to dominate the medical gas market with the highest market share

The pure gases from the product type segment are expected to dominate the medical gas market with the highest market share.

Pure gases, including oxygen, nitrogen, nitrous oxide, carbon dioxide, and helium, are high-purity, single-component gases used in therapeutic applications, anaesthesia, respiratory treatments, diagnostic imaging, and pharmaceutical manufacturing due to their unique physiological and chemical properties.

The demand for pure medical gases is increasing due to respiratory disorders like COPD and asthma, surgical procedures requiring anaesthesia gases, and biotechnology and pharmaceutical research applications.

Advancements in gas delivery systems, stringent regulatory standards, and the growing adoption of home healthcare services fuel market growth. For instance, in October 2023, Bausch + Lomb Corporation launched its Pure-line gas range in Europe, available in pure or premixed iterations of SF6, C2F6, and C3F8. This is the latest addition to the company's surgical retina portfolio, which includes intraocular dyes for posterior and anterior staining, as well as intraocular dyes for anterior staining.

Geographical Analysis

North America is expected to hold a significant position in the medical gas market with the highest market share

North America is expected to hold a significant position in the medical gas market with the highest market share. The North American medical gas market is fueled by rising respiratory diseases, geriatric populations, and surgical procedures requiring anaesthesia gases. Also, Regulatory support and stringent safety standards ensure the widespread adoption of medical gas systems in hospitals, ambulatory surgical centres, and research facilities.

Moreover, significant partnerships, advancements in healthcare infrastructure, and expanding home healthcare services contribute to market growth. For instance, in March 2025, Meritus Gas Partners partnered with Oxygen Service Company, a leading independent distributor of packaged gases and welding supplies based in Saint Paul, Minnesota. OSC, a 100% employee-owned company, offers a wide range of products and services, including industrial, specialty, and medical gases, automation equipment, and welding and safety supplies.

Competitive Landscape

The major global players in the medical gas market include Air Liquide, Linde plc, Air Products and Chemicals, Inc., Messer Group GmbH, SOL Group, Matheson Tri-Gas, Inc., Atlas Copco, GCE Group, Nova Gas Technologies, and Gruppo SIAD, among others.

Key Developments

  • In January 2025, INOX Air Products, India's largest industrial gases manufacturer, inaugurated the country's first ultra-high purity electronic grade nitrous oxide plant in Manali, Chennai, with a capacity of 1,700 tonnes per annum, ensuring high purity.
  • In July 2024, Adenia Partners acquired Air Liquide's operations in 12 African countries, forming Erium, the first pan-African leader in industrial and medical gases. Erium will replace Air Liquide in Benin, Burkina Faso, Cameroon, Congo, Cote d'Ivoire, Gabon, Ghana, Madagascar, Mali, the Democratic Republic of Congo, Senegal, and Togo.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical gas market report delivers a detailed analysis with 62 key tables, more than 55 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

3. Market Highlights and Strategic Takeaways

  • 3.1. Key Trends and Future Projections

4. Snippet by Product Type

  • 4.1. Snippet by Application
  • 4.2. Snippet by End-User
  • 4.3. Snippet by Region

5. Dynamics

  • 5.1. Impacting Factors
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Respiratory Disorders
      • 5.1.1.2. Technological Advancements in Medical Gas Delivery Systems
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent Regulatory Requirements
      • 5.1.2.2. High Cost of Medical Gas Equipment and Infrastructure
    • 5.1.3. Opportunity
      • 5.1.3.1. Increasing Healthcare Investments in Emerging Markets
    • 5.1.4. Impact Analysis

6. Strategic Insights and Industry Outlook

  • 6.1. Market Leaders and Pioneers
    • 6.1.1. Emerging Pioneers and Prominent Players
    • 6.1.2. Established leaders with largest selling Brand
    • 6.1.3. Market leaders with established Product
  • 6.2. CXO Perspectives
  • 6.3. Latest Developments and Breakthroughs
  • 6.4. Case Studies/Ongoing Research
  • 6.5. Regulatory and Reimbursement Landscape
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. Asia Pacific
    • 6.5.4. Latin America
    • 6.5.5. Middle East & Africa
  • 6.6. Porter's Five Force Analysis
  • 6.7. Supply Chain Analysis
  • 6.8. Patent Analysis
  • 6.9. SWOT Analysis
  • 6.10. Unmet Needs and Gaps
  • 6.11. Recommended Strategies for Market Entry and Expansion
  • 6.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 6.13. Pricing Analysis and Price Dynamics
  • 6.14. Key Opinion Leaders

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Pure Gases*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gas Mixtures
  • 7.4. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Respiratory Therapy*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Cardiovascular Therapy
  • 8.4. Anesthesia
  • 8.5. Cryosurgery
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals & Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers (ASCs)
  • 9.4. Home Healthcare
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Regional Market Analysis and Growth Opportunities

11. Introduction

  • 11.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.1. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.6.1. U.S.
      • 11.2.6.2. Canada
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.6.1. Germany
      • 11.3.6.2. U.K.
      • 11.3.6.3. France
      • 11.3.6.4. Spain
      • 11.3.6.5. Italy
      • 11.3.6.6. Rest of Europe
  • 11.4. Latin America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.6.1. Mexico
      • 11.4.6.2. Brazil
      • 11.4.6.3. Argentina
      • 11.4.6.4. Rest of Latin America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.6.1. China
      • 11.5.6.2. India
      • 11.5.6.3. Japan
      • 11.5.6.4. South Korea
      • 11.5.6.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape and Market Positioning

13. Competitive Overview and Key Market Players

  • 13.1. Market Share Analysis and Positioning Matrix
  • 13.2. Strategic Partnerships, Mergers & Acquisitions
  • 13.3. Key Developments in Product Portfolios and Innovations
  • 13.4. Company Benchmarking

14. Company Profiles

  • 14.1. Air Liquide*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio
      • 14.1.2.1. Product Description
      • 14.1.2.2. Product Key Performance Indicators (KPIs)
      • 14.1.2.3. Historic and Forecasted Product Sales
      • 14.1.2.4. Product Sales Volume

15. Financial Overview

  • 15.1. Company Revenue's
    • 15.1.1. Geographical Revenue Shares
      • 15.1.1.1. Revenue Forecasts
    • 15.1.2. Key Developments
      • 15.1.2.1. Mergers & Acquisitions
      • 15.1.2.2. Key Product Development Activities
      • 15.1.2.3. Regulatory Approvals, etc.
    • 15.1.3. SWOT Analysis
  • 15.2. Linde plc
  • 15.3. Air Products and Chemicals, Inc.
  • 15.4. Messer Group GmbH
  • 15.5. SOL Group
  • 15.6. Matheson Tri-Gas, Inc.
  • 15.7. Atlas Copco
  • 15.8. GCE Group
  • 15.9. Nova Gas Technologies
  • 15.10. Gruppo SIAD (LIST NOT EXHAUSTIVE)

16. Assumption and Research Methodology

  • 16.1. Data Collection Methods
  • 16.2. Data Triangulation
  • 16.3. Forecasting Techniques
  • 16.4. Data Verification and Validation

17. Appendix

  • 17.1. About Us and Services
  • 17.2. Contact Us